Yamagishi S - Search Results

1

Renoprotective effects of azelnidipine, a dihydropyridine-based calcium antagonist in advanced glycation end product (AGE)-injected rats.

Yamagishi S, Takeuchi M, Inoue H. Yamagishi S, et al. Int J Tissue React. 2005;27(3):137-43. Int J Tissue React. 2005. PMID: 16372480

2

Can we identify genes for susceptibility to diabetic microangiopathies using stroke-prone spontaneously hypertensive rat models?

Yamagishi S, Takeuchi M, Unoki H. Yamagishi S, et al. Med Hypotheses. 2001 Apr;56(4):510-2. doi: 10.1054/mehy.2000.1257. Med Hypotheses. 2001. PMID: 11339857

3

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H. Yamamoto Y, et al. Among authors: yamagishi s. J Clin Invest. 2001 Jul;108(2):261-8. doi: 10.1172/JCI11771. J Clin Invest. 2001. PMID: 11457879 Free PMC article.

4

Advanced glycation end products and the pathogenesis of diabetic nephropathy.

Yamagishi S, Takeuchi M, Makita Z. Yamagishi S, et al. Contrib Nephrol. 2001;(134):30-5. doi: 10.1159/000060150. Contrib Nephrol. 2001. PMID: 11665285 Review. No abstract available.

5

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

Yamagishi S, Amano S, Inagaki Y, Okamoto T, Koga K, Sasaki N, Yamamoto H, Takeuchi M, Makita Z. Yamagishi S, et al. Biochem Biophys Res Commun. 2002 Jan 25;290(3):973-8. doi: 10.1006/bbrc.2001.6312. Biochem Biophys Res Commun. 2002. PMID: 11798169

6

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.

Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, Makita Z. Yamagishi S, et al. J Biol Chem. 2002 Jun 7;277(23):20309-15. doi: 10.1074/jbc.M202634200. Epub 2002 Mar 23. J Biol Chem. 2002. PMID: 11912219 Free article.

7

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

Sasaki N, Takeuchi M, Chowei H, Kikuchi S, Hayashi Y, Nakano N, Ikeda H, Yamagishi S, Kitamoto T, Saito T, Makita Z. Sasaki N, et al. Among authors: yamagishi s. Neurosci Lett. 2002 Jun 28;326(2):117-20. doi: 10.1016/s0304-3940(02)00310-5. Neurosci Lett. 2002. PMID: 12057842

8

Palmitate-induced apoptosis of microvascular endothelial cells and pericytes.

Yamagishi S, Okamoto T, Amano S, Inagaki Y, Koga K, Koga M, Choei H, Sasaki N, Kikuchi S, Takeuchi M, Makita Z. Yamagishi S, et al. Mol Med. 2002 Apr;8(4):179-84. Mol Med. 2002. PMID: 12149567 Free PMC article.

9

Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.

Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z. Yamagishi S, et al. Biochem Biophys Res Commun. 2002 Aug 30;296(4):877-82. doi: 10.1016/s0006-291x(02)00940-3. Biochem Biophys Res Commun. 2002. PMID: 12200129

10

Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.

Okamoto T, Yamagishi S, Inagaki Y, Amano S, Takeuchi M, Kikuchi S, Ohno S, Yoshimura A. Okamoto T, et al. Among authors: yamagishi s. Biochem Biophys Res Commun. 2002 Sep 20;297(2):419-24. doi: 10.1016/s0006-291x(02)02218-0. Biochem Biophys Res Commun. 2002. PMID: 12237136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

931 results

Search Page

Filters